Recent developments in topoisomerase-targeted cancer chemotherapy

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• DNA topoisomerases are vital enzymes regulating DNA topology during replication and transcription.
• These enzymes are key targets for antimicrobial and anticancer chemotherapeutic agents.
• Natural products like camptothecin and anthracyclines are established cancer treatments.

Purpose of the Study:

• To review clinically used topoisomerase inhibitors for cancer therapy.
• To discuss the pharmacology and chemistry of novel topoisomerase inhibitors in development.

Main Methods:

• Literature review of existing and emerging topoisomerase inhibitors.
• Analysis of clinical and preclinical data on drug efficacy and mechanisms.

Main Results:

• Overview of established topoisomerase inhibitors in cancer treatment.
• Identification of promising new agents in clinical and preclinical stages.

Conclusions:

• Targeting DNA topoisomerases remains a critical strategy in cancer therapy.
• Ongoing research focuses on developing more selective and effective inhibitors.